Erik Meyer
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Liver Diseases and Immunity
-
- Liver Disease Diagnosis and Treatment
Papers in
-
- TGF-β signaling in diseases 2
- Ubiquitin and proteasome pathways 1
- Glycosylation and Glycoproteins Research 1
-
- Liver physiology and pathology 4
- Co-authors
- Peter R. Galle (5 shared papers)Stephan Kanzler (4 shared papers)Peter Schirmacher (3 shared papers)Ansgar W. Lohse (3 shared papers)F Thieringer (4 shared papers)Borut Klopcic (2 shared papers)Johannes Herkel (2 shared papers)Stefan Biesterfeld (1 shared paper)
- Journals
- Journal of Hepatology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Oncogene (1 paper)Molecular Carcinogenesis (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Erik Meyer
9 papers receiving 385 citations
Peers
Comparison fields: 5 of 73
- Hepatology 165
- Epidemiology 109
- Urology 16
- Oncology 67
- Immunology 42
Countries citing papers authored by Erik Meyer
This map shows the geographic impact of Erik Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Meyer more than expected).
Fields of papers citing papers by Erik Meyer
This network shows the impact of papers produced by Erik Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Meyer. The network helps show where Erik Meyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 208 | |
| 2 | 2001 | 55 | |
| 3 | 2007 | 41 | |
| 4 | 2011 | 23 | |
| 5 | 2005 | 23 | |
| 6 | 2005 | 23 | |
| 7 | 2004 | 11 | |
| 8 | 1971 | 9 | |
| 9 | 1988 | 1 |
About Erik Meyer
Erik Meyer is a scholar working on Molecular Biology, Hepatology, Oncology, Immunology and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 394 indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), TGF-β signaling in diseases (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Ubiquitin and proteasome pathways (1 paper), Glycosylation and Glycoproteins Research (1 paper), Chemokine receptors and signaling (1 paper), T-cell and B-cell Immunology (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hepatology (165 citations), Epidemiology (109 citations), Urology (16 citations), Oncology (67 citations) and Immunology (42 citations). Erik Meyer has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Peter R. Galle, Stephan Kanzler, Peter Schirmacher, Ansgar W. Lohse, F Thieringer, Borut Klopcic, Johannes Herkel, Stefan Biesterfeld, Manfred Blessing and T Maass. Their work appears in journals such as Journal of Hepatology, Biochemical and Biophysical Research Communications, Oncogene, Molecular Carcinogenesis and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.